Skip to main content
Clinical Trials/NCT06076733
NCT06076733RecruitingNot Applicable

To Explore the Intervention Effect of High Definition-transcranial Alternating Current Stimulation (HD-tACS) on Consciousness Promotion in Patients With Chronic Consciousness Disorders and the Potential Neural Mechanism

Anhui Medical University1 site in 1 country40 target enrollmentStarted: September 21, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
Assessment of Coma Recovery Scale

Study Overview

Brief Summary

To investigate the effect of high definition-transcranial alternating current stimulation(HD-tACS) on consciousness promotion in patients with chronic consciousness disorders and the underlying neural mechanism by EEG.

Detailed Description

Forty patients with chronic consciousness disorder who met the inclusion criteria were recruited with the informed consent of the family. All the participants were randomized to receive "active" or "sham" treatment protocol. Stimulation was performed using a alternating stimulator linked to one anodal electrode and four cathodal electrodes. The anodal electrode was placed over the left dorsolateral prefrontal cortex (DLPFC; F3 in the 10-20 international system of EEG placement), and the four cathodal electrodes (AFz, FCz, F7, and C5 in the 10-20 international system EEG placement) were placed around the anodal electrode to form a current loop. Twenty 2 milliampere (mA) sessions (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 20 minutes per session, twice daily over 10 consecutive days, and the stimulus frequency was set as 6 Hertz (Hz). Sham tACS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds. Before and after the tACS treatment, the state of consciousness was assessed according to coma recovery scale-revised(CRS-R), and19-channel EEG data were collected.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients diagnosed as chronic disorders of consciousness based on CRS-R assessment by at least two professional neurologists;
  • •the age requirement is between 18 and 75;
  • •vital signs need to be stable;
  • •no neuromuscular blockers and sedatives have been used within 24 hours before the study and the entire protocol;
  • •no improvement in the state of consciousness was observed within one week before the start of the study.

Exclusion Criteria

  • •previous or current diagnosis of severe neurocognitive degenerative diseases;
  • •metal implantation in the head;
  • •previous surgical procedures resulted in skull defect;
  • •previous history of epilepsy.

Arms & Interventions

active group

Experimental

Twenty 2-mA sessions (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 20 minutes per session, twice daily over 10 consecutive days, and the stimulus frequency was set as 6Hz.

Intervention: high definition-transcranial alternating current stimulation (Device)

sham group

Sham Comparator

Sham tACS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.

Intervention: sham transcranial alternating current stimulation (Device)

Outcomes

Primary Outcomes

Assessment of Coma Recovery Scale

Time Frame: Before intervention and one day after all intervention

State of consciousness was assessed by two trained physicians in three different time periods using the Coma Recovery Scale-Revised (CRS-R), which has demonstrated good reliability and validity for the behavioral evaluation of disorder of consciousness (DOC) patients. Total score ranges from zero to twenty-three, with higher scores indicating better neurological function and prognosis.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Anhui Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

WANG KAI

Director of medical psychological department, Anhui Medical University

Anhui Medical University

Study Sites (1)

Loading locations...

Similar Trials

Intervention Effect of Transcranial... | Clinical Trial